pre-update Archives

Blog

靶向放射治疗的剂量优化考量

The acquisitions of targeted radiation therapy companies (TRT) Point Biopharma by Eli Lilly and RayzeBio…

Certara2024 年 2 月 16 日

Publication

The interaction of core modules as a basis for elucidating network behavior determining Parkinson’s disease pathogenesis

It is well-established that misfolded alpha-synuclein (alpha-syn) is a histopathological marker of Parkinson's disease. Given…

Certara2024 年 2 月 14 日

On-Demand Webinar

IND 申报提速秘诀：How to Expedite IND Filing with a Subscription Model

When choosing how to accomplish your IND submission, there can be many elements to the…

Certara2024 年 2 月 13 日

Conference

The 15th Japan Safety Pharmacology Society

Certara2024 年 2 月 13 日

Brochure

ToxStudio®: Secondary Intelligence™ 常见问题解答

Certara2024 年 2 月 9 日

Video

D360 Scientific Informatics Discovery Platform: User Stories

Transcript: I've joined companies both blueprint medicines and score therapeutics is one of the first…

Certara2024 年 2 月 8 日

Press Coverage

Upping the Ante for Predicting the Success of Alzheimer Disease Treatments

By Hugo Geerts, PhD, Piet van der Graaf, PharmD, PhD Over the past 20 years,…

Certara2024 年 2 月 8 日

Conference

Clinical Data Disclosure, Transparency & Plain Language Summaries 2024

Certara2024 年 2 月 7 日

Conference

DIA MASC

Certara2024 年 2 月 2 日

On-Demand Webinar

Drug Development’s New Model: Biosimulation from Discovery to Label Expansion

Key Highlights: How predictive technologies reshape drug development, mitigating project risks, navigating novel biomarkers, predicting…

Certara2024 年 2 月 2 日

pre-update

靶向放射治疗的剂量优化考量

The interaction of core modules as a basis for elucidating network behavior determining Parkinson’s disease pathogenesis

IND 申报提速秘诀：How to Expedite IND Filing with a Subscription Model

The 15th Japan Safety Pharmacology Society

ToxStudio®: Secondary Intelligence™ 常见问题解答

D360 Scientific Informatics Discovery Platform: User Stories

Upping the Ante for Predicting the Success of Alzheimer Disease Treatments

Clinical Data Disclosure, Transparency & Plain Language Summaries 2024

DIA MASC

Drug Development’s New Model: Biosimulation from Discovery to Label Expansion

订阅时事通讯

快捷链接

解决方案

联系我们